This research study is studying a research drug called AZD6738 as a possible treatment for Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia .
Leukemia, Myelodysplastic Syndrome
This research study is studying a research drug called AZD6738 as a possible treatment for Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia .
AZD6738 for Patients With Progressive MDS or CMML
-
BIDMC, Boston, Massachusetts, United States, 02215
Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States, 02215
Washington University, Saint Louis, Missouri, United States, 63110
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Massachusetts General Hospital,
Andrew M Brunner, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital
2025-05-31